The BioAI Phase Shift: A Podcast with Chai Discovery's Co-founder and Product Lead

This article announces a podcast interview with Chai Discovery co-founder Matthew McPartlon and product lead Neil Patil. The discussion covers the recent surge in AI-pharma tool deals at the JPM conference, and how AI tools have become trustworthy enough to accelerate drug discovery and enable new capabilities. Chai Discovery, valued at $4B, is highlighted despite being only two years old.